Mérieux Equity Partners is a Lyon and Paris healthcare investor; its Innovation platform backs medical innovation from seed to Series B with €3M to €15M per company. Mérieux Innovation 2 invested in Ona Therapeutics (June 2026) and HighLife Medical (September 2026), and co-led deepull's €50M round in April 2025.
Auto-extracted from press releases.
Auto-detected from Mérieux Equity Partners's website.
Investors that share at least two portfolio companies with Mérieux Equity Partners.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.